A Study of LY2940094 in Participants With Alcohol Dependency

NCT01798303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcoholism

Interventions

DRUG: LY2940094
DRUG: Placebo

Sponsor

BlackThorn Therapeutics, Inc.